Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.
about
Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancerSequencing of treatment in metastatic colorectal cancer: where to fit the targetMonoclonal Antibodies in Cancer Therapy: Mechanisms, Successes and Limitations.Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.
P2860
Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Which is false: oxaliplatin or ...... receptor monoclonal antibody.
@en
Which is false: oxaliplatin or ...... receptor monoclonal antibody.
@nl
type
label
Which is false: oxaliplatin or ...... receptor monoclonal antibody.
@en
Which is false: oxaliplatin or ...... receptor monoclonal antibody.
@nl
prefLabel
Which is false: oxaliplatin or ...... receptor monoclonal antibody.
@en
Which is false: oxaliplatin or ...... receptor monoclonal antibody.
@nl
P2093
P2860
P356
P1433
P1476
Which is false: oxaliplatin or ...... receptor monoclonal antibody.
@en
P2093
Pengfei Zhang
Qiancheng Hu
Ruilei Tang
Xiaofeng He
Yaxiong Sang
P2860
P304
P356
10.1111/CAS.12224
P577
2013-07-30T00:00:00Z